EMAIL THIS PAGE TO A FRIEND

Journal of molecular medicine (Berlin, Germany)

Inhibition of protein tyrosine phosphatases enhances cerebral collateral growth in rats.


PMID 24858946

Abstract

Arteriogenesis involves the rapid proliferation of preexisting arterioles to fully functional arteries as a compensatory mechanism to overcome circulatory deficits. Stimulation of arteriogenesis has therefore been considered a treatment concept in arterial occlusive disease. Here, we investigated the impact of inhibition of protein tyrosine phosphatases (PTPs) on cerebral arteriogenesis in rats. Arteriogenesis was induced by occlusion of one carotid and both vertebral arteries (three-vessel occlusion (3-VO)). Collateral growth and functional vessel perfusion was assessed 3-35xa0days following 3-VO. Furthermore, animals underwent 3-VO surgery and were treated with the pan-PTP inhibitor BMOV, the SHP-1 inhibitor sodium stibogluconate (SSG), or the PTP1B inhibitor AS279. Cerebral vessel diameters and cerebrovascular reserve capacity (CVRC) were determined, together with immunohistochemistry analyses and proximity ligation assays (PLA) for determination of tissue proliferation and phosphorylation patterns after 7xa0days. The most significant changes in vessel diameter increase were present in the ipsilateral posterior cerebral artery (PCA), with proliferative markers (PCNA) being time-dependently increased. The CVRC was lost in the early phase after 3-VO and partially recovered after 21xa0days. PTP inhibition resulted in a significant increase in the ipsilateral PCA diameter in BMOV-treated animals and rats subjected to PTP1B inhibition. Furthermore, CVRC was significantly elevated in AS279-treated rats compared to control animals, along with hyperphosphorylation of the platelet-derived growth factor-β receptor in the vascular wall in vivo. In summary, our data indicate PTPs as hitherto unrecognized negative regulators in cerebral arteriogenesis. Further, PTP inhibition leading to enhanced collateral growth and blood perfusion suggests PTPs as novel targets in anti-ischemic treatment. PTPs exhibit negative regulatory function in cerebral collateral growth in rats. Inhibition of pan-PTP/PTP1B increases vessel PDGF-β receptor phosphorylation. PTP1B inhibition enhances arteriogenesis and cerebrovascular reserve capacity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2101628
Anti-NR0B2 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2101629
Anti-NR0B2 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB2101630
Anti-NR0B2 (ab3) antibody produced in rabbit, affinity isolated antibody
SAB2101631
Anti-NR0B2 (ab4) antibody produced in rabbit, affinity isolated antibody
SAB1406664
Anti-NR0B2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1306059 ANTI-PTP1B (N-TERMINAL) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1306060 ANTI-PTP1B antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
GW21488 Anti-PTPN1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1406342
Anti-PTPN1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA012542
Anti-PTPN1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV45360
Anti-PTPN1 antibody produced in rabbit, affinity isolated antibody
SAB1411155
Anti-PTPN1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4300558
Anti-PTPN6 (Ab-536) antibody produced in rabbit, affinity isolated antibody
SAB1406344
Anti-PTPN6 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA001466
Anti-PTPN6 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
GW21487 Anti-PTPNS1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1408349
Anti-SIRPA antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2102154
Anti-SIRPA antibody produced in rabbit, affinity isolated antibody
WH0008431M1
Monoclonal Anti-NR0B2 antibody produced in mouse, clone 1A11, purified immunoglobulin, buffered aqueous solution
SAB1305532 MONOCLONAL ANTI-PTP1B antibody produced in mouse, clone 107AT690, IgG fraction of antiserum, buffered aqueous solution
WH0140885M1
Monoclonal Anti-PTPNS1 antibody produced in mouse, clone 1D10, purified immunoglobulin, buffered aqueous solution